This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mason, D. Immunol. Today 19, 395–404 (1998).
Laugel, B. et al. J. Biol. Chem. 280, 1882–1892 (2005).
Foote, J. & Eisen, H.N. Proc. Natl. Acad. Sci. USA 97, 10679–10681 (2000).
Holler, P.D. et al. Proc. Natl. Acad. Sci. USA 97, 5387–5392 (2000).
Kieke, M.C. et al. Proc. Natl. Acad. Sci. USA 96, 5651–5656 (1999).
Shusta, E.V., Holler, P.D., Kieke, M.C., Kranz, D.M. & Wittrup, K.D. Nat. Biotechnol. 18, 754–759 (2000).
Li, Y. et al. Nat. Biotechnol. 23, 349–354 (2005).
Molloy, P.E., Sewell, A.K. & Jakobsen, B.K. Curr. Opin. Pharmacol. 5, 438–443 (2005).
Chames, P., Hufton, S.E., Coulie, P.G., Uchanska-Ziegler, B. & Hoogenboom, H.R. Proc. Natl. Acad. Sci. USA 97, 7969–7974 (2000).
Denkberg, G. et al. Proc. Natl. Acad. Sci. USA 99, 9421–9426 (2002).
Hulsmeyer, M. et al. J. Biol. Chem. 280, 2972–2980 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laugel, B., Price, D. & Sewell, A. On the path to TCR-directed therapeutics. Nat Biotechnol 24, 615–616 (2006). https://doi.org/10.1038/nbt0606-615b
Issue Date:
DOI: https://doi.org/10.1038/nbt0606-615b